- Home
- LDWY vs MYNZ Comparison
LDWY vs MYNZ Comparison
Compare LDWY & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- MYNZ
- Stock Information
- Founded
- LDWY 1990
- MYNZ 2021
- Country
- LDWY United States
- MYNZ Germany
- Employees
- LDWY N/A
- MYNZ N/A
- Industry
- LDWY Advertising
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- MYNZ Health Care
- Exchange
- LDWY Nasdaq
- MYNZ Nasdaq
- Market Cap
- LDWY 7.2M
- MYNZ 7.9M
- IPO Year
- LDWY 1991
- MYNZ 2021
- Fundamental
- Price
- LDWY $3.88
- MYNZ $1.41
- Analyst Decision
- LDWY
- MYNZ Buy
- Analyst Count
- LDWY 0
- MYNZ 2
- Target Price
- LDWY N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- LDWY 20.0K
- MYNZ 798.7K
- Earning Date
- LDWY 11-10-2025
- MYNZ 12-29-2025
- Dividend Yield
- LDWY N/A
- MYNZ N/A
- EPS Growth
- LDWY N/A
- MYNZ N/A
- EPS
- LDWY 0.70
- MYNZ N/A
- Revenue
- LDWY $69,769,000.00
- MYNZ $659,935.00
- Revenue This Year
- LDWY N/A
- MYNZ N/A
- Revenue Next Year
- LDWY N/A
- MYNZ $5.03
- P/E Ratio
- LDWY $5.26
- MYNZ N/A
- Revenue Growth
- LDWY 121.91
- MYNZ N/A
- 52 Week Low
- LDWY $3.43
- MYNZ $1.21
- 52 Week High
- LDWY $6.19
- MYNZ $10.56
- Technical
- Relative Strength Index (RSI)
- LDWY 39.52
- MYNZ 45.75
- Support Level
- LDWY $3.54
- MYNZ $1.21
- Resistance Level
- LDWY $4.10
- MYNZ $2.09
- Average True Range (ATR)
- LDWY 0.45
- MYNZ 0.17
- MACD
- LDWY -0.05
- MYNZ 0.00
- Stochastic Oscillator
- LDWY 8.04
- MYNZ 22.74
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in industries: Specialty Ag, consisting of the Bloomia business.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.